Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2022
8 years of board service in total across 3 boards, counting each seat separately. Longest: Disc Medicine Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Agios Pharmaceuticals Inc. | Grant or award | +1,447 | — | — |
| Mar 10, 2025 | Scholar Rock Holding Corporation | Grant or award | +113,570 | — | — |
| Feb 18, 2025 | Scholar Rock Holding Corporation | Open-market sale | −18,372 | $36.83 | $676,641 |
| Jan 16, 2025 | Scholar Rock Holding Corporation | Open-market sale | −22,308 | $44.20 | $986,014 |
| Feb 16, 2024 | Scholar Rock Holding Corporation | Open-market sale | −11,614 | $15.74 | $182,804 |
| Feb 12, 2024 | Scholar Rock Holding Corporation | Grant or award | +214,285 | — | — |
| Feb 13, 2023 | Scholar Rock Holding Corporation | Grant or award | +150,000 | — | — |
Questions about Jay T. Backstrom
What boards is Jay T. Backstrom on?
Jay T. Backstrom sits on the boards of Agios Pharmaceuticals Inc., Disc Medicine Inc. and Scholar Rock Holding Corporation.
What company is Jay T. Backstrom the CEO of?
Jay T. Backstrom is CHIEF EXECUTIVE OFFICER of Scholar Rock Holding Corporation.
How long has Jay T. Backstrom served on boards?
Our records show at least 8 years of board service across 3 boards, the earliest from 2022.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.